MoneyWorks4Me

Solara Active Pharma Sciences informs about press release

30 Jan 2023 Evaluate

Solara Active Pharma Sciences has informed that it attached press release issued by the Company titled: ‘USFDA concludes inspection at Solara’s Visakhapatnam (Vizag) facility with zero 483 inspectional observations.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1849.00
Dr. Reddys Labs. 1198.40
Cipla 1399.00
Lupin 2084.00
Zydus Lifesciences 1196.45
View more..